Theranostic Potentials of Gold Nanomaterials in Hematological Malignancies

SIMPLE SUMMARY: Hematological malignancies (HMs) cover 50% of all malignancies, and people of all ages can be affected by these deadly diseases. In many cases, conventional diagnostic tools fail to diagnose HMs at an early stage, due to heterogeneity and the long-term indolent phase of HMs. Therefor...

Descripción completa

Detalles Bibliográficos
Autores principales: Shakil, Md Salman, Niloy, Mahruba Sultana, Mahmud, Kazi Mustafa, Kamal, Mohammad Amjad, Islam, Md Asiful
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264814/
https://www.ncbi.nlm.nih.gov/pubmed/35804818
http://dx.doi.org/10.3390/cancers14133047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264814/
https://www.ncbi.nlm.nih.gov/pubmed/35804818
http://dx.doi.org/10.3390/cancers14133047

Ejemplares similares